Table 1 Connectivity scores of small compounds with repurposing potential against SARS-CoV-2 as predicted by various studies
Compounds | Score | Reference |
|---|---|---|
Emetine | 99.61 | (Dyall et al., 2014) [23] |
Chloroquine | -45.51 | |
mefloquine | -3.93 | |
Amodiaquine | -13.11 | |
Gemcitabine | 1.59 | |
Tamoxifen | -23.6 | |
Toremifene | -17.23 | |
Terconazole | -14.17 | |
Anisomycin | 99.58 | |
cycloheximide | 99.86 | |
Homoharringtonine | 99.51 | |
Fluspirilene | -35.73 | |
Thiothixene | -1.66 | |
Fluphenazine | 17.51 | |
Chlorpromazine | -77.85 | |
Triflupromazine | -0.35 | |
Clomipramine | -11.65 | |
Imatinib | -1.34 | |
Dasatinib | -75.92 | |
Vidarabine | -2.82 | (Micholas and Jeremy C., 2020) [24] |
eriodictyol | -13.82 | |
phenformin | 1.23 | |
Apicidin | 86.32 | (Gordon et al., 2020) [4] |
Haloperidol | -0.74 | |
Entacapone | 6.41 | |
Metformin | 4.37 | |
H-89 | -82.31 | |
Ribavirin | 7.17 | |
Midostaurin | 48.43 | |
Ruxolitinib | 91.54 | |
Daunorubicin | -73.76 | |
Captopril | 13.92 | |
Chloramphenicol | -21.3 | |
Linezolid | 17.29 | |
Irbesartan | 1.09 | (Y. Zhou et al., 2020) [25] |
Equilin | 22.26 | |
Mesalazine | 7.09 | |
Mercaptopurine | 6.02 | |
Paroxetine | -1.84 | |
Sirolimus | 95.45 | |
Carvedilol | -13.58 | |
Dactinomycin | -39.25 | |
Eplerenone | 10.74 | |
Oxymetholone | -2.34 |